SCYNEXIS Inc. diskutieren
SCYNEXIS Inc.
WKN: A2P9T4 / Symbol: SCYX / Name: SCYNEXIS / Aktie / Pharmazeutika / Small Cap /
2,10 €
-2,23 %
SCYNEXIS, Inc. (NASDAQ: SCYX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Ratings data for SCYX provided by MarketBeat
SCYNEXIS, Inc. (NASDAQ: SCYX) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $15.00 price target on the stock.
Ratings data for SCYX provided by MarketBeat
SCYNEXIS, Inc. (NASDAQ: SCYX) had its price target raised by analysts at Guggenheim from $8.00 to $9.00. They now have a "buy" rating on the stock.
Ratings data for SCYX provided by MarketBeat
SCYNEXIS, Inc. (NASDAQ: SCYX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $15.00 price target on the stock.
Ratings data for SCYX provided by MarketBeat
SCYNEXIS, Inc. (NASDAQ: SCYX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for SCYX provided by MarketBeat
SCYNEXIS, Inc. (NASDAQ: SCYX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for SCYX provided by MarketBeat
Neueste Beiträge
Loop_Capital in Alibaba Group Holding Ltd ADR diskutieren